86520-63-0

Basic information

• Product Name: .alpha.-D-Galactopyranose, 2,3,4,6-tetraacetate 1-(2,2,2-trichloroethanimidate)
• Synonyms: .alpha.-D-Galactopyranose, 2,3,4,6-tetraacetate 1-(2,2,2-trichloroethanimidate);GLACTOSE TRICHLOROACETIMIDATE;2,3,4,6-Tetra-O-acetyl-alpha-D-galactopyranosyl 2,2,2-Trichloroacetimidate;α-D-Galactopyranose, 2,3,4,6-Tetraacetate 1-(2,2,2-TrichloroethaniMidate);2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl 2,2,2-TrichloroacetiMidate;-D-galactopyranosyl 2,2,2-Trichloroacetimidate;2,3,4,6-Tetra-O-acetyl-&alpha
• CAS NO: 86520-63-0
• Molecular Formula: C₁₆H₂₀Cl₃NO₁₀
• Molecular Weight: 492.69
• Product Categories: Biochemistry;Galactose;Imidate sugars;O-Substituted Sugars;Sugars;Carbohydrates & Derivatives
• Mol File: 86520-63-0.mol
• Article Data: 88

Chemical Properties

• Melting Point: 121 °C
• Boiling Point: 463.341°C at 760 mmHg
• Flash Point: 234.02°C
• Appearance: /
• Density: 1.558g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.552
• Storage Temp.: Freezer
• CAS DataBase Reference: .alpha.-D-Galactopyranose, 2,3,4,6-tetraacetate 1-(2,2,2-trichloroethanimidate)(CAS DataBase Reference)
• NIST Chemistry Reference: .alpha.-D-Galactopyranose, 2,3,4,6-tetraacetate 1-(2,2,2-trichloroethanimidate)(86520-63-0)
• EPA Substance Registry System: .alpha.-D-Galactopyranose, 2,3,4,6-tetraacetate 1-(2,2,2-trichloroethanimidate)(86520-63-0)

Safety Data

• Hazardous Substances Data: 86520-63-0(Hazardous Substances Data)

Usage

Chemical Properties

White Solid

Uses

2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl Trichloroacetimidate (cas# 86520-63-0) is a compound useful in organic synthesis.

InChI:InChI=1/C16H20Cl3NO10/c1-6(21)25-5-10-11(26-7(2)22)12(27-8(3)23)13(28-9(4)24)14(29-10)30-15(20)16(17,18)19/h10-14,20H,5H2,1-4H3/t10-,11-,12-,13-,14+/m0/s1

Upstream product

• 3947-62-4 2,3,4,5-tetra-O-acetyl-D-glucopyranose 
• 545-06-2 trichloroacetonitrile 
• 604-69-3 β-D-glucose pentaacetate 
• 604-68-2 α-D-glucopyranose peracetylate 
• 83-87-4 D-glucose pentaacetate 
• 50-99-7 D-glucose 
• 13992-16-0 phenyl 2,3,4,6-tetra-O-acetyl-1-thio-α,β-D-glucopyranoside 
• 3947-62-4 2,3,4,6-tetra-O-acetyl-α/β-D-galactopyranose 
• 70191-05-8 2,3,4,6-tetra-O-acetyl-β-D-galactopyranose 
• 3947-62-4 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside 
• 83-87-4 penta-O-acetyl-α-D-galactopyranose 
• 59-23-4 D-Galactose 
• 3646-73-9 α-D-galactopyranose 
• 10257-28-0 D-Galactose 

Downstream Products

• 141263-06-1 4-Methoxybenzyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside 
• 190448-62-5 Acetic acid (S)-1-(4-fluoro-phenyl)-3-{(3R,4S)-1-(4-fluoro-phenyl)-2-oxo-4-[4-((2S,3R,4S,5R,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-phenyl]-azetidin-3-yl}-propyl ester 
• 3947-62-4 2,3,4,6-tetra-O-acetyl-α/β-D-galactopyranose 
• 201737-04-4 6-benzyloxycarbonylaminohexyl β-D-galactopyranoside 
• 53691-39-7 benzyl 3,4,6-tri-O-acetyl-β-D-glucopyranoside 
• 10343-13-2 benzyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside 
• 31281-76-2 O-benzyl-2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside 
• 10343-13-2 benzyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside 
• 142696-63-7 O-benzyl-2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside 
• 52571-61-6 O-(4-iodophenyl)-(2,3,4,6-O-tetraacetyl)-α-D-galactopyranose 
• 52571-61-6 O-(4-iodophenyl)-(2,3,4,6-O-tetraacetyl)-β-D-galactopyranose 
• 868992-17-0 O-[3-(4-phenylmethoxyphenyl)-1-propyl]-(2,3,4,6-O-tetraacetyl)-β-D-galacto-pyranose 
• 881425-86-1 Acetic acid (2R,3R,4S,5S,6R)-4,5-diacetoxy-6-acetoxymethyl-2-{(2R,4aR,6S,7R,8R,8aS)-7-acetylamino-6-[dimethyl-(1,1,2-trimethyl-propyl)-silanyloxy]-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy}-tetrahydro-pyran-3-yl ester 
• 161976-09-6 phenyl (2,3,4,6-tetra-O-acetyl-β-D-galacto-pyranosyl)-(1->6)-2,3,4-tri-O-acetyl-1-thio-β-D-glucopyranoside 

Relevant articles and documents

Synthesis of malformin-A1, C, a glycan, and an aglycon analog: Potential scaffolds for targeted cancer therapy

Improvement in therapeutic efficacy while reducing chemotherapeutic side effects remains a vital objective in synthetic design for cancer treatment. In keeping with the ethos of therapeutic development and inspired by the Warburg effect for augmenting biological activities of the malformin family of cyclic-peptide natural products, specifically anti-tumor activity, a β-glucoside of malformin C has been designed and synthesized utilizing precise glycosylation and solution phase peptide synthesis. We optimized several glycosylation procedures utilizing different donors and acceptors. The overarching goal of this study was to ensure a targeted delivery of a glyco-malformin C analog through the coupling of D-glucose moiety; selective transport via glucose transporters (GLUTs) into tumor cells, followed by hydrolysis in the tumor microenvironment releasing the active malformin C a glycon analog. Furthermore, total synthesis of malformin C was carried out with overall improved strategies avoiding unwanted side reactions thus increasing easier purification. We also report on an improved solid phase peptide synthesis protocol for malformin A1.

1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

-

Nitrogen-containing aromatic ring derivative containing galactose and application thereof

The invention belongs to the technical field of medicines, and relates to a nitrogen-containing aromatic ring derivative containing galactose, application thereof and a pharmaceutical composition containing the compound. The invention also relates to a method for preparing the compound and the pharmaceutical composition, and application of the compound and the pharmaceutical composition in prevention or treatment of tumors, inflammatory diseases, autoimmune diseases and other diseases, especially tumors.